140 related articles for article (PubMed ID: 20977728)
1. Whole-liver radiotherapy for end-stage colorectal cancer patients with massive liver metastases and advanced hepatic dysfunction.
Yeo SG; Kim DY; Kim TH; Kim SY; Hong YS; Jung KH
Radiat Oncol; 2010 Oct; 5():97. PubMed ID: 20977728
[TBL] [Abstract][Full Text] [Related]
2. Whole-liver radiotherapy concurrent with chemotherapy as a palliative treatment for colorectal patients with massive and multiple liver metastases: a retrospective study.
Yin H; Lu K; Qiao WB; Zhang HY; Sun D; You QS
Asian Pac J Cancer Prev; 2014; 15(4):1597-602. PubMed ID: 24641374
[TBL] [Abstract][Full Text] [Related]
3. Combined liver radiation and chemotherapy for palliation of hepatic metastases from colorectal cancer.
Mohiuddin M; Chen E; Ahmad N
J Clin Oncol; 1996 Mar; 14(3):722-8. PubMed ID: 8622017
[TBL] [Abstract][Full Text] [Related]
4. [The value of radiotherapy for liver metastases].
Eble MJ; Gademann G; Wannenmacher M
Strahlenther Onkol; 1993 Aug; 169(8):459-68. PubMed ID: 7689254
[TBL] [Abstract][Full Text] [Related]
5. Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases.
Allen-Mersh TG; Earlam S; Fordy C; Abrams K; Houghton J
Lancet; 1994 Nov; 344(8932):1255-60. PubMed ID: 7526096
[TBL] [Abstract][Full Text] [Related]
6. Carbon-ion Radiotherapy for Oligometastatic Colorectal Cancer in the Liver or Lung.
Shiba S; Shibuya K; Okamoto M; Okano N; Kubo N; Kaminuma T; Sato H; Okazaki S; Miyasaka Y; Kawamura H; Ohno T
Anticancer Res; 2021 Apr; 41(4):1997-2005. PubMed ID: 33813406
[TBL] [Abstract][Full Text] [Related]
7. Yttrium 90 resin microspheres for the treatment of unresectable colorectal hepatic metastases after failure of multiple chemotherapy regimens: preliminary results.
Murthy R; Xiong H; Nunez R; Cohen AC; Barron B; Szklaruk J; Madoff DC; Gupta S; Wallace MJ; Ahrar K; Hicks ME
J Vasc Interv Radiol; 2005 Jul; 16(7):937-45. PubMed ID: 16002501
[TBL] [Abstract][Full Text] [Related]
8. Biokinetics of a F(ab')3 iodine-131 labeled antigen binding construct (Mab 35) directed against CEA in patients with colorectal carcinoma.
Storto G; Buchegger F; Waibel R; Kuenzi G; Offord RE; Schubiger PA; Gillet M; Delaloye AB
Cancer Biother Radiopharm; 2001 Oct; 16(5):371-9. PubMed ID: 11776754
[TBL] [Abstract][Full Text] [Related]
9. Unresectable hepatic metastases from carcinoma of the colon and rectum.
Didolkar MS; Elias EG; Whitley NO; Keramati B; Jackson AJ; Hebel RJ; Jordan TE
Surg Gynecol Obstet; 1985 May; 160(5):429-36. PubMed ID: 3992446
[TBL] [Abstract][Full Text] [Related]
10. Conformal radiotherapy of the dominant liver metastasis: a viable strategy for treatment of unresectable chemotherapy refractory colorectal cancer liver metastases.
Krishnan S; Lin EH; Gunn GB; Chandra A; Beddar AS; Briere TM; Das P; Delclos ME; Janjan NA; Crane CH
Am J Clin Oncol; 2006 Dec; 29(6):562-7. PubMed ID: 17148992
[TBL] [Abstract][Full Text] [Related]
11. Hepatic yttrium-90 radioembolization of chemotherapy-refractory colorectal cancer liver metastases.
Jakobs TF; Hoffmann RT; Dehm K; Trumm C; Stemmler HJ; Tatsch K; La Fougere C; Murthy R; Helmberger TK; Reiser MF
J Vasc Interv Radiol; 2008 Aug; 19(8):1187-95. PubMed ID: 18656012
[TBL] [Abstract][Full Text] [Related]
12. Preoperative Aspartate Aminotransferase-to-Platelet Ratio Index Predicts Perioperative Liver-Related Complications Following Liver Resection for Colorectal Cancer Metastases.
Amptoulach S; Gross G; Sturesson C; Rissler P; Kalaitzakis E
Scand J Surg; 2017 Dec; 106(4):311-317. PubMed ID: 28737112
[TBL] [Abstract][Full Text] [Related]
13. Liver function tests in patients with computed tomography demonstrated hepatic metastases.
Ottmar MD; Gonda RL; Leithauser KJ; Gutierrez OH
Gastrointest Radiol; 1989; 14(1):55-8. PubMed ID: 2910745
[TBL] [Abstract][Full Text] [Related]
14. Is carcino-embryonic antigen useful in the follow-up management of patients with colorectal liver metastases?
Bakalakos EA; Burak WE; Young DC; Martin EW
Am J Surg; 1999 Jan; 177(1):2-6. PubMed ID: 10037299
[TBL] [Abstract][Full Text] [Related]
15. Whole Liver Palliative Radiotherapy for Patients with Massive Liver Metastases.
Edyta WR; Jakub L; Jerzy W
Asian Pac J Cancer Prev; 2015; 16(15):6381-4. PubMed ID: 26434846
[TBL] [Abstract][Full Text] [Related]
16. The relationship between hypoalbuminaemia, tumour volume and the systemic inflammatory response in patients with colorectal liver metastases.
Al-Shaiba R; McMillan DC; Angerson WJ; Leen E; McArdle CS; Horgan P
Br J Cancer; 2004 Jul; 91(2):205-7. PubMed ID: 15213726
[TBL] [Abstract][Full Text] [Related]
17. Carcinoembryonic antigen and intra-arterial chemotherapy response of liver metastases.
Hanazaki K; Kawamura N; Sodeyama H; Wakabayashi M; Yokoyama S; Sode Y; Miyazaki T; Okazaki Y
Hepatogastroenterology; 1998; 45(20):462-7. PubMed ID: 9638428
[TBL] [Abstract][Full Text] [Related]
18. A prospective study of current diagnostic procedures for assessment of hepatic metastases in colorectal cancers.
Arnaud JP; Thibaud D; Leguillou A; Bergamaschi R; Adloff M
Eur J Surg Oncol; 1987 Aug; 13(4):355-8. PubMed ID: 2887457
[TBL] [Abstract][Full Text] [Related]
19. Selective internal radiation therapy with 90Y microspheres for colorectal liver metastases: single-centre experience with 100 patients.
Stubbs RS; O'Brien I; Correia MM
ANZ J Surg; 2006 Aug; 76(8):696-703. PubMed ID: 16916386
[TBL] [Abstract][Full Text] [Related]
20. Hepatocellular carcinoma and liver cirrhosis: assessment of the liver function after Yttrium-90 radioembolization with resin microspheres or after CT-guided high-dose-rate brachytherapy.
Rühl R; Seidensticker M; Peters N; Mohnike K; Bornschein J; Schütte K; Amthauer H; Malfertheiner P; Pech M; Ricke J
Dig Dis; 2009; 27(2):189-99. PubMed ID: 19546558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
